Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -6.77% is 60% above its 5-year average of -17.09%, around the middle of its 5-year range (-42.17%–62.33%).
35.60% above its 12-month average of -10.51%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 1.11%.
NET PROFIT MARGIN
-6.77%
NET PROFIT MARGIN AVG TTM
-10.51%
NET PROFIT MARGIN AVG 3Y
-11.85%
NET PROFIT MARGIN AVG 5Y
-17.09%
NET PROFIT MARGIN AVG 10Y
-8.16%
NET PROFIT MARGIN AVG 15Y
-4.00%
NET PROFIT MARGIN AVG 20Y
-5.61%
CURRENT VS TTM AVG
+35.60%
CURRENT VS 3Y AVG
+42.85%
CURRENT VS 5Y AVG
+60.39%
CURRENT VS 10Y AVG
+16.99%
CURRENT VS 15Y AVG
-69.18%
CURRENT VS 20Y AVG
-20.66%
SECTOR MEDIAN · HEALTHCARE
8.68%
median of 98 covered companies
CURRENT VS SECTOR MEDIAN
-178.00%
vs the sector median at left
NeoGenomics, Inc.
Market Cap
$470.35M
Net Profit Margin
-6.77%
TTM Avg
-10.51%
3Y Avg
-11.85%
5Y Avg
-17.09%
Market Cap
$389.98M
Net Profit Margin
-58.33%
TTM Avg
-67.34%
3Y Avg
-66.78%
5Y Avg
-66.78%
Market Cap
$41.24M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.01B
Net Profit Margin
-7.13%
TTM Avg
-23.45%
3Y Avg
-155.72%
5Y Avg
-114.72%
Market Cap
$1.71B
Net Profit Margin
-672.16%
TTM Avg
-753.31%
3Y Avg
-935.73%
5Y Avg
-797.48%
Market Cap
$1.74B
Net Profit Margin
-14.99%
TTM Avg
-20.12%
3Y Avg
-16.95%
5Y Avg
-10.04%
Market Cap
$2.13B
Net Profit Margin
-945.92%
TTM Avg
-825.68%
3Y Avg
-750.64%
5Y Avg
-1236.10%
Market Cap
$2.49B
Net Profit Margin
-54.75%
TTM Avg
-325.19%
3Y Avg
-290.00%
5Y Avg
-135445.82%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| NeoGenomics, Inc. (NEO) | $470.35M | -6.77% | -10.51% | -11.85% | -17.09% |
| NRC Health (NRC)vs › | $459.30M | 4.18% | 12.88% | 16.89% | 20.14% |
| Shoulder Innovations, Inc. (SI)vs › | $389.98M | -58.33% | -67.34% | -66.78% | -66.78% |
| PDS Biotechnology Corporation (PDSB)vs › | $41.24M | 0.00% | 0.00% | 0.00% | 0.00% |
| Teladoc Health, Inc. (TDOC)vs › | $1.01B | -7.13% | -23.45% | -155.72% | -114.72% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.71B | -672.16% | -753.31% | -935.73% | -797.48% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.74B | -14.99% | -20.12% | -16.95% | -10.04% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.13B | -945.92% | -825.68% | -750.64% | -1236.10% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.49B | -54.75% | -325.19% | -290.00% | -135445.82% |
| TransMedics Group, Inc. (TMDX)vs › | $2.72B | 22.69% | 19.73% | -2.42% | -44.65% |
Operating Margin
-8.6%
Net Profit Margin
-6.8%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 1.11% |
| 2026-03-31 | -9.16% |
| 2025-12-31 | -5.20% |
| 2025-09-30 | -14.45% |
| 2025-06-30 | -24.87% |
| 2025-03-31 | -15.43% |
| 2024-12-31 | -8.91% |
| 2024-09-30 | -10.55% |
| 2024-06-30 | -11.33% |
| 2024-03-31 | -17.32% |
| 2023-12-31 | -9.21% |
| 2023-09-30 | -12.19% |
| 2023-06-30 | -16.56% |
| 2023-03-31 | -22.44% |
| 2022-12-31 | -16.36% |
| 2022-09-30 | -28.62% |
| 2022-06-30 | -28.23% |
| 2022-03-31 | -42.17% |
| 2021-12-31 | -33.21% |
| 2021-09-30 | -16.77% |
| 2021-06-30 | 62.33% |
| 2021-03-31 | -19.14% |
| 2020-12-31 | 12.24% |
| 2020-09-30 | 2.04% |
| 2020-06-30 | -7.85% |
| 2020-03-31 | -6.58% |
| 2019-12-31 | 5.89% |
| 2019-09-30 | 2.05% |
| 2019-06-30 | 1.96% |
| 2019-03-31 | -2.54% |
| 2018-12-31 | 0.46% |
| 2018-09-30 | 2.93% |
| 2018-06-30 | -0.56% |
| 2018-03-31 | 1.02% |
| 2017-12-31 | 7.30% |
| 2017-09-30 | -6.76% |
| 2017-06-30 | 0.78% |
| 2017-03-31 | -1.89% |
| 2016-12-31 | -10.29% |
| 2016-09-30 | -0.11% |
| 2016-06-30 | 0.65% |
| 2016-03-31 | 0.26% |
| 2015-12-31 | -5.40% |
| 2015-09-30 | -0.50% |
| 2015-06-30 | -0.72% |
| 2015-03-31 | -3.30% |
| 2014-12-31 | 4.19% |
| 2014-09-30 | -1.25% |
| 2014-06-30 | 1.33% |
| 2014-03-31 | 0.56% |
| 2013-12-31 | 4.68% |
| 2013-09-30 | 5.33% |
| 2013-06-30 | 1.75% |
| 2013-03-31 | 0.02% |
| 2012-12-31 | -0.76% |
| 2012-09-30 | -6.87% |
| 2012-06-30 | 3.53% |
| 2012-03-31 | 3.98% |
| 2011-12-31 | 1.18% |
| 2011-09-30 | -1.26% |
| 2011-06-30 | -2.80% |
| 2011-03-31 | -10.14% |
| 2010-12-31 | -4.31% |
| 2010-09-30 | -13.76% |
| 2010-06-30 | -11.52% |
| 2010-03-31 | -8.91% |
| 2009-12-31 | -19.61% |
| 2009-09-30 | -10.35% |
| 2009-06-30 | 0.11% |
| 2009-03-31 | 0.48% |
| 2008-12-31 | -16.79% |
| 2008-09-30 | -3.86% |
| 2008-06-30 | 1.48% |
| 2008-05-13 | -6.37% |
| 2007-12-31 | -42.06% |
| 2007-09-30 | -18.92% |
| 2007-06-30 | -41.55% |
| 2007-05-11 | -9.81% |
| 2006-12-31 | -24.33% |
| 2006-09-30 | 1.99% |
| 2006-06-30 | 9.13% |
| 2006-03-31 | 7.92% |
| 2005-12-31 | -48.08% |
| 2005-09-30 | -42.91% |
| 2005-06-30 | -52.48% |
| 2005-03-31 | -93.40% |
| 2004-12-31 | -228.24% |
| 2004-09-30 | -140.33% |
| 2004-06-30 | -139.06% |
| 2004-03-31 | -95.04% |
| 2003-12-31 | -105.45% |
| 2003-09-30 | -153.05% |
| 2003-06-30 | -190.11% |
| 2003-03-31 | -163.61% |
| 2002-12-31 | 2560.47% |
| 2002-09-30 | -2626.57% |
